NIC:ASXNickel Industries Limited Analysis
Data as of 2026-05-24 - not real-time
A$1.01
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
NIC has delivered a **28% revenue growth** year‑over‑year, pushing total revenue to AUD 292.9 million. Its margins are exceptionally strong, with a gross margin of 40.7% and an operating margin of 33.7%, while profit margin sits at 42.3%. The company posted a positive forward EPS of 0.1385 AUD, translating to a forward P/E of just 7.3×, well below the market average. Analysts (7 in total) have issued a *strong‑buy* consensus and set a mean target price of AUD 1.22, implying roughly 20% upside from the current AUD 1.01 level. Recent earnings calls highlighted an EBITDA surge driven by pricing gains in nickel and cobalt, reinforcing the growth narrative. However, free cash flow remains negative at –AUD 73 million and debt‑to‑equity is elevated at 9.0×, raising cash‑flow sustainability concerns.
Technically, the stock trades above its 50‑day SMA (0.98 AUD) but below the 20‑day SMA (1.05 AUD), and the MACD histogram is negative, suggesting short‑term bearish pressure. Volume has been on a decreasing trend, and the RSI sits at 46, indicating a neutral momentum environment. The price is comfortably above the identified support level of 0.98 AUD but still below the 52‑week high of 1.125 AUD, leaving room for upside. The DCF‑derived fair value of 0.24 AUD is far below the market price, flagging a potential overvaluation from a discounted‑cash‑flow perspective. With a beta of 0.75 and 30‑day volatility of 35%, the stock exhibits moderate market sensitivity but higher price swings. The dividend yield of 3.94% is attractive, yet a payout ratio above 100% combined with negative cash flow questions its long‑term sustainability.
Technically, the stock trades above its 50‑day SMA (0.98 AUD) but below the 20‑day SMA (1.05 AUD), and the MACD histogram is negative, suggesting short‑term bearish pressure. Volume has been on a decreasing trend, and the RSI sits at 46, indicating a neutral momentum environment. The price is comfortably above the identified support level of 0.98 AUD but still below the 52‑week high of 1.125 AUD, leaving room for upside. The DCF‑derived fair value of 0.24 AUD is far below the market price, flagging a potential overvaluation from a discounted‑cash‑flow perspective. With a beta of 0.75 and 30‑day volatility of 35%, the stock exhibits moderate market sensitivity but higher price swings. The dividend yield of 3.94% is attractive, yet a payout ratio above 100% combined with negative cash flow questions its long‑term sustainability.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price hovering just above support at 0.98 AUD
- Negative MACD histogram indicating short‑term bearish pressure
- Volume decreasing, suggesting waning short‑term buying interest
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong revenue growth (28%) and high profit margins
- Forward P/E of 7.3× and analyst mean target price of 1.22 AUD
- Upside potential of ~20% based on target price versus current price
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Elevated debt‑to‑equity ratio (9.0×) and negative free cash flow
- Dividend payout ratio >100% questioning sustainability
- DCF fair value (0.24 AUD) far below market price, indicating valuation concerns
Key Metrics & Analysis
Financial Health
Revenue Growth2811.80%
Profit Margin42.33%
P/E Ratio7.3
ROE35.37%
ROA10.14%
Debt/Equity9.00
P/B Ratio2.8
Op. Cash FlowA$43.2M
Free Cash FlowA$-73174608
Technical Analysis
TrendBullish
RSI46.3
SupportA$0.98
ResistanceA$1.13
MA 20A$1.05
MA 50A$0.98
MA 200A$0.85
MACDBearish
VolumeDecreasing
Fear & Greed Index91.61
Valuation
Fair ValueA$0.24
Target PriceA$1.22
Upside/Downside20.75%
GradeOvervalued
TypeGrowth
Dividend Yield3.94%
Risk Assessment
Beta0.75
Volatility35.46%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.